Lauren A Flieller, C. Alaniz, Melissa R. Pleva, James T. Miller
{"title":"Incidence of Rebound Hypertension after Discontinuation of Dexmedetomidine","authors":"Lauren A Flieller, C. Alaniz, Melissa R. Pleva, James T. Miller","doi":"10.1002/phar.2323","DOIUrl":null,"url":null,"abstract":"To date, no studies have evaluated the incidence of rebound hypertension occurring with the discontinuation of long‐term (> 72 hrs) dexmedetomidine infusions. Rebound hypertension has been documented in the literature with clonidine, a structurally and pharmacologically similar medication.","PeriodicalId":19812,"journal":{"name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/phar.2323","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
To date, no studies have evaluated the incidence of rebound hypertension occurring with the discontinuation of long‐term (> 72 hrs) dexmedetomidine infusions. Rebound hypertension has been documented in the literature with clonidine, a structurally and pharmacologically similar medication.